Kawasaki H
Second Department of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1997 Nov;72(6):649-65.
The present study was undertaken to determine how the responses to contractile agents are altered in aortas from rats with streptozotocin-induced diabetes and to explore the possible mechanisms of the altered responses in diabetes. Rats were given an intravenous injection of 45 mg/kg streptozotocin. Eight to 12 weeks after treatment, aortas were isolated and set up for measurement of isometric tension. Diabetic aortas exhibited significantly lesser contractions in response to high K+ than those from age-matched controls. Furthermore, the Ca2+ channel agonist Bay K 8644 was not able to consistently contract diabetic aortas even when they were partially depolarized by an elevation of the extracellular K+ concentration to 15 mM where the agonist produced concentration-dependent contractions in all control aortas. On the other hand, the contractile responses to norepinephrine, 5-hydroxytryptamine, endothelin-1 and U46619 were significantly enhanced in diabetic rat aortas. All of the enhanced responses of diabetic aortas were completely eliminated in the presence of the Ca2+ channel antagonist nifedipine. The contractile responses of aortas from both control and diabetic rats to these agonists were abolished or strongly inhibited by the protein kinase C inhibitor staurosporine, and no significant difference was found in the magnitude of the contractile responses of aortas between control and diabetic rats to the agonists in the presence of staurosporine. In diabetic aortas, the protein kinase C activators phorbol 12, 13-dibutyrate and 12-O-tetradecanoylphorbol 13-acetate elicited a delayed, sharply developing rise in tension following the initial, gradually developing contraction, while these agents produced only the initial, slowly developing contraction in control aortas. As a result, the contractions induced by phorbol esters were greater in diabetic aortas than in controls. The enhanced contractile responses of diabetic aortas to phorbol esters were not observed in Ca(2+)-free medium or in the presence of nifedipine. In Ca(2+)-free medium, the transient contraction induced by caffeine was significantly diminished in diabetic aortas, in contrast to the phasic contraction by norepinephrine which was similarly observed in control and diabetic aortas. These results indicate that the extracellular Ca(2+)-dependent contractions elicited by receptor activation are enhanced in aortas from diabetic rats, and this is presumably related to a greater influx of Ca2+ through transmembrane Ca2+ channels as a consequence of increased protein kinase C-activated processes. On the other hand, the contractions associated with depolarization-evoked activation of Ca2+ channels are diminished in diabetic aortas, possibly due to an alteration in activation of the channels by membrane depolarization, and Ca(2+)-induced Ca2+ release from intracellular stores appears to be impaired in diabetes.
本研究旨在确定链脲佐菌素诱导的糖尿病大鼠主动脉对收缩剂的反应如何改变,并探讨糖尿病中反应改变的可能机制。给大鼠静脉注射45mg/kg链脲佐菌素。治疗8至12周后,分离主动脉并设置用于测量等长张力。糖尿病主动脉对高钾的收缩反应明显小于年龄匹配的对照组。此外,即使细胞外钾浓度升高至15mM使糖尿病主动脉部分去极化,Ca2+通道激动剂Bay K 8644也不能使糖尿病主动脉持续收缩,而在所有对照主动脉中该激动剂产生浓度依赖性收缩。另一方面,糖尿病大鼠主动脉对去甲肾上腺素、5-羟色胺、内皮素-1和U46619的收缩反应明显增强。在存在Ca2+通道拮抗剂硝苯地平的情况下,糖尿病主动脉的所有增强反应均完全消除。蛋白激酶C抑制剂星形孢菌素消除或强烈抑制对照和糖尿病大鼠主动脉对这些激动剂的收缩反应,并且在存在星形孢菌素的情况下,对照和糖尿病大鼠主动脉对激动剂的收缩反应幅度没有发现显著差异。在糖尿病主动脉中,蛋白激酶C激活剂佛波醇12,13-二丁酸酯和12-O-十四酰佛波醇13-乙酸酯在初始逐渐发展的收缩后引起延迟的、急剧发展的张力升高,而这些药物在对照主动脉中仅产生初始缓慢发展的收缩。结果,佛波醇酯诱导的收缩在糖尿病主动脉中比在对照中更大。在无Ca(2+)培养基中或在存在硝苯地平的情况下未观察到糖尿病主动脉对佛波醇酯的增强收缩反应。在无Ca(2+)培养基中,咖啡因诱导的瞬时收缩在糖尿病主动脉中明显减弱,与去甲肾上腺素引起的相性收缩相反,后者在对照和糖尿病主动脉中类似地观察到。这些结果表明,受体激活引起的细胞外Ca(2+)依赖性收缩在糖尿病大鼠主动脉中增强,这可能与蛋白激酶C激活过程增加导致通过跨膜Ca2+通道的Ca2+流入增加有关。另一方面,与去极化诱发的Ca2+通道激活相关的收缩在糖尿病主动脉中减弱,可能是由于膜去极化对通道激活的改变,并且糖尿病中细胞内钙库的Ca(2+)诱导的Ca2+释放似乎受损。